+23.5%
NVDA vs EMR
+15.3%
+8.2%
-20.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +2.6% | -2.6% | -1.0% |
| 7D | -5.1% | -0.4% | -4.7% | -5.0% |
| 30D | -2.5% | -6.8% | +4.3% | 0.0% |
| 3M | +6.7% | +7.5% | -0.8% | +3.8% |
| 6M | +17.6% | +9.9% | +7.8% | +12.2% |
| YTD | +17.3% | +16.0% | +1.4% | +7.9% |
| 1Y | +23.5% | +12.4% | +11.1% | +15.5% |
| All | +23.5% | +15.3% | +8.2% | +15.5% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling